Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use

  • Read more about Minimally Immunogenic Variants of SDR-Grafted Humanized Antibody CC49 and Their Use
US Application 60/498,903
Filed on 2003-08-29

Cytotoxic Indeno- And Isoindoloisoquinoline

  • Read more about Cytotoxic Indeno- And Isoindoloisoquinoline
US Application 60/469,718
Filed on 2003-05-12

ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS)

  • Read more about ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS)
US Application 10/445,430
Filed on 2003-05-27

New Building Blocks For DNA Binding Agents

  • Read more about New Building Blocks For DNA Binding Agents
US Application 60/508,543
Filed on 2003-10-03

Gene Expressed In Breast Cancer And Method of Use

  • Read more about Gene Expressed In Breast Cancer And Method of Use
US Application 60/493,522
Filed on 2003-08-08

Gene Expression Is Silenced In Chromosomal Amplicons In Colorectal Carcinomas (CRC)

  • Read more about Gene Expression Is Silenced In Chromosomal Amplicons In Colorectal Carcinomas (CRC)
US Application 60/340,124
Filed on 2001-12-13

Treatment Method of Kidney Cancer

  • Read more about Treatment Method of Kidney Cancer
US Application 60/369,868
Filed on 2002-04-05

Potent Combinations Of mRNA Transport Elements

  • Read more about Potent Combinations Of mRNA Transport Elements
US Application 60/472,223
Filed on 2003-05-20

Peptides for the Induction of an Immune Response to Vaccinia Virus and Their Use

  • Read more about Peptides for the Induction of an Immune Response to Vaccinia Virus and Their Use
US Application 60/512,039
Filed on 2003-10-16

Polypetides and Peptide Fragments From the SARS-COV S Protein as Antigens and Immunogens

  • Read more about Polypetides and Peptide Fragments From the SARS-COV S Protein as Antigens and Immunogens
US Application 60/489,166
Filed on 2003-07-21

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • Page 180
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health